Robert A.

Robert A. has a diverse work experience spanning several industries and roles. Robert is currently serving as the Vice President, Insights, Analytics & Forecasting at Sage Therapeutics since April 2022. Prior to this, they had a successful stint at AstraZeneca where they held multiple roles, including Head of Insights & Analytics Center of Excellence, Global and US from July 2019 to April 2022, and Head of US Insights & Analytics from May 2017 to July 2019.

Robert A. also served on the Executive Committee of the Board of Trustees at the Marketing Science Institute from October 2017 to October 2020. At Teva Pharmaceuticals, they held the position of Vice President, Business Intelligence / Insights & Analytics from 2015 to May 2017. Earlier in their career, Robert A. worked at Bristol-Myers Squibb in various positions, including Vice President, Customer Insight & Analytics and Commercialization Excellence - WW & US Pharma, Vice President, Customer Insight & Analytics - WW & US Pharmaceuticals, and Executive Director Brand Lead, Sprycel - U.S. Oncology.

Before joining Bristol-Myers Squibb, Robert A. gained experience at Procter & Gamble, where they held roles such as Assistant Brand Manager, Prilosec, Assistant Brand Manager, Healthcare Business Development, Volume Forecasting / Pre-Market Testing Senior Supervisor, and Senior Market Research Manager.

Overall, Robert A. brings a wealth of experience in insights, analytics, and market research to their current role at Sage Therapeutics.

Robert A. has a Double degree in B.S. Marketing and B.S. Decision Sciences from Miami University. Robert also holds an MBA with a focus on Finance from Xavier University.